Company Announcements

Disclosure of Rights Attached to Securities

Source: RNS
RNS Number : 7120P
Novolipetsk Steel
11 June 2020

Press release

11 June 2020

Disclosure of Rights Attached to Securities

NLMK Group (LSE: NLMK), a global steel company with operations in Russia, the USA, and the EU, announces that in compliance with Listing Rules 14.3.11R and 18.4.3R, it has forwarded to the FCA for publication a copy of:

·    the Prospectus dated 9 December 2005 in respect of its global depositary shares and the ordinary shares underlying them

·    the Charter as approved by the General Shareholders' Meeting of NLMK on 21 December 2018.

The documents set out the rights attached to the global depositary shares and the ordinary shares underlying them.

The aforementioned documents have been submitted to the National Storage Mechanism and will shortly be available for inspection at


IR contact info:

Dmitry Kolomytsyn, CFA

+7 (495) 504 0 504

Media contact info:

Mariya Simonova

+7 (915) 322 62 25


About NLMK Group

NLMK Group is the largest steelmaker in Russia and one of the most efficient in the world.

NLMK Group's steel products are used in various industries, from construction and machine building to the manufacturing of power-generation equipment and offshore wind turbines.

NLMK operates production facilities in Russia, Europe and the United States. The Company's steel production capacity exceeds 17 million tonnes per year.NLMK's ordinary shares with a 18.6% free-float are traded on the Moscow Stock Exchange (ticker "NLMK") and its global depositary shares are traded on the London Stock Exchange (ticker "NLMK:LI"). The share capital of the Company is divided into 5,993,227,240 shares with a par value of RUB1. For more details on NLMK shareholder capital please follow the link.

For more information about NLMK Group, please visit our website.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit